Irritable bowel syndrome: the burden and unmet needs in Europe.

Hdl Handle:
http://hdl.handle.net/10147/208835
Title:
Irritable bowel syndrome: the burden and unmet needs in Europe.
Authors:
Quigley, E M M; Bytzer, P; Jones, R; Mearin, F
Affiliation:
Alimentary Pharmabiotic Centre, Department of Medicine, National University of, Ireland, Cork University Hospital, Wilton, Cork, Ireland. e.quigley@ucc.ie
Citation:
Dig Liver Dis. 2006 Oct;38(10):717-23. Epub 2006 Jun 27.
Journal:
Digestive and liver disease : official journal of the Italian Society of, Gastroenterology and the Italian Association for the Study of the Liver
Issue Date:
3-Feb-2012
URI:
http://hdl.handle.net/10147/208835
DOI:
10.1016/j.dld.2006.05.009
PubMed ID:
16807154
Abstract:
Irritable bowel syndrome affects approximately 10-15% of the European population, although prevalence rates vary depending on the classification used and the country surveyed. This may be due to differences in patterns of medical care and diagnosis of the condition. Up to 70% of individuals with irritable bowel syndrome may not have been formally diagnosed. The disorder affects 1.5-3 times as many women as men and poses a significant economic burden in Europe, estimated at euro 700-euro 1600 per person per year. It also reduces quality of life and is associated with psychological distress, disturbed work and sleep, and sexual dysfunction. It is a chronic disorder, which affects many individuals for more than 10 years. Most patients are managed in primary care, although some are referred to gastroenterologists and other specialists. Patients with irritable bowel syndrome undergo more abdomino-pelvic surgery than the general population. We propose that a positive diagnosis of the condition may avoid the delay in diagnosis many patients experience. We conclude that, in Europe, there are significant unmet needs including lack of familiarity with irritable bowel syndrome, difficulties in diagnosis and lack of effective treatments for the multiple symptoms of the disorder. The development of pan-European guidelines for irritable bowel syndrome will benefit patients with this condition in Europe.
Language:
eng
MeSH:
Cost of Illness; Europe/epidemiology; Health Care Costs; Humans; Irritable Bowel Syndrome/economics/*epidemiology/therapy; Prevalence; Quality of Life
ISSN:
1590-8658 (Print); 1590-8658 (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorQuigley, E M Men_GB
dc.contributor.authorBytzer, Pen_GB
dc.contributor.authorJones, Ren_GB
dc.contributor.authorMearin, Fen_GB
dc.date.accessioned2012-02-03T15:04:55Z-
dc.date.available2012-02-03T15:04:55Z-
dc.date.issued2012-02-03T15:04:55Z-
dc.identifier.citationDig Liver Dis. 2006 Oct;38(10):717-23. Epub 2006 Jun 27.en_GB
dc.identifier.issn1590-8658 (Print)en_GB
dc.identifier.issn1590-8658 (Linking)en_GB
dc.identifier.pmid16807154en_GB
dc.identifier.doi10.1016/j.dld.2006.05.009en_GB
dc.identifier.urihttp://hdl.handle.net/10147/208835-
dc.description.abstractIrritable bowel syndrome affects approximately 10-15% of the European population, although prevalence rates vary depending on the classification used and the country surveyed. This may be due to differences in patterns of medical care and diagnosis of the condition. Up to 70% of individuals with irritable bowel syndrome may not have been formally diagnosed. The disorder affects 1.5-3 times as many women as men and poses a significant economic burden in Europe, estimated at euro 700-euro 1600 per person per year. It also reduces quality of life and is associated with psychological distress, disturbed work and sleep, and sexual dysfunction. It is a chronic disorder, which affects many individuals for more than 10 years. Most patients are managed in primary care, although some are referred to gastroenterologists and other specialists. Patients with irritable bowel syndrome undergo more abdomino-pelvic surgery than the general population. We propose that a positive diagnosis of the condition may avoid the delay in diagnosis many patients experience. We conclude that, in Europe, there are significant unmet needs including lack of familiarity with irritable bowel syndrome, difficulties in diagnosis and lack of effective treatments for the multiple symptoms of the disorder. The development of pan-European guidelines for irritable bowel syndrome will benefit patients with this condition in Europe.en_GB
dc.language.isoengen_GB
dc.subject.meshCost of Illnessen_GB
dc.subject.meshEurope/epidemiologyen_GB
dc.subject.meshHealth Care Costsen_GB
dc.subject.meshHumansen_GB
dc.subject.meshIrritable Bowel Syndrome/economics/*epidemiology/therapyen_GB
dc.subject.meshPrevalenceen_GB
dc.subject.meshQuality of Lifeen_GB
dc.titleIrritable bowel syndrome: the burden and unmet needs in Europe.en_GB
dc.contributor.departmentAlimentary Pharmabiotic Centre, Department of Medicine, National University of, Ireland, Cork University Hospital, Wilton, Cork, Ireland. e.quigley@ucc.ieen_GB
dc.identifier.journalDigestive and liver disease : official journal of the Italian Society of, Gastroenterology and the Italian Association for the Study of the Liveren_GB
dc.description.provinceMunster-

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.